Intestine Transplant Outcomes

At a Glance

• First transplant: 08/22/2010
• Transplants performed in 2021: 1
• Total number of program transplants through 2021: 41
• Received Medicare approval: 2/8/2013

Outcomes

• Median time to transplant<: 3.3 months, compared with 8.4 months nationally
• Pre-transplant mortality~: .00 (expected .125, national .064)
• Transplant rates~: .776 (expected .875, national .677)

Patient survival rates for multivisceral transplant:*

• Henry Ford one-year patient survival rate: 100.00%
• Henry Ford three-year patient survival rate: 56.24%

Graft survival rate for multivisceral transplant:+

• Henry Ford one-year graft survival rate: 100.00%
• Henry Ford three-year graft survival rate: 33.33%

< Patients on the waitlist between 01/01/2016 and 06/30/2021
~ Patients on the waitlist between 01/01/2020 – 03/12/2020 and 06/13/2020 – 12/31/2021
*Estimated probability of surviving at one year, for patients receiving their first transplant between 01/01/2019 – 03/12/2020 and 06/13/2020 – 06/30/2021; and at three years, for patients receiving their first transplant between 07/01/2016 and 12/31/2018
^ Adjusted for patient and donor characteristics
+ Estimated probability of surviving with a functioning graft at one year, for patients receiving their first transplant between 01/01/2019 – 03/12/2020 and 06/13/2020 – 06/30/2021; and at three years, for patients receiving their first transplant between 07/01/2016 and 12/31/2018

Source: Scientific Registry of Transplant Recipients, Center and OPO-specific Reports, based on data available April 30, 2022, released July 6, 2022.

Milestones in Intestine and Multivisceral Transplantation

• First in Michigan to perform a modified multivisceral (stomach, intestinal and pancreas) transplant (2010)